Biopharma

Statins May Reduce Risk for Hepatocellular Carcinoma in Chronic Liver Disease

Statins May Reduce Risk for Hepatocellular Carcinoma in...

Mar 19, 2025 0

WEDNESDAY, March 19, 2025 -- For patients with chronic liver disease, statin us...

Graph Neural Network Can Detect Epileptogenic Focal Cortical Dysplasia

Graph Neural Network Can Detect Epileptogenic Focal Cor...

Mar 19, 2025 0

WEDNESDAY, March 19, 2025 -- A graph neural network using data from the Multice...

American Academy of Dermatology, March 7 to 11

American Academy of Dermatology, March 7 to 11

Mar 19, 2025 0

The annual meeting of the American Academy of Dermatology was held from March 7 ...

Tirzepatide, Semaglutide Not Cost-Effective at Current Prices

Tirzepatide, Semaglutide Not Cost-Effective at Current ...

Mar 19, 2025 0

WEDNESDAY, March 19, 2025 -- Tirzepatide and semaglutide offer long-term health...

Prevalence of Pediatric-Onset Chronic Conditions, Functional Limitations Increasing

Prevalence of Pediatric-Onset Chronic Conditions, Funct...

Mar 19, 2025 0

WEDNESDAY, March 19, 2025 -- The prevalence of chronic conditions (CC) and func...

Clinical Guidelines Updated for Evaluation, Management, Treatment of CKD

Clinical Guidelines Updated for Evaluation, Management,...

Mar 19, 2025 0

WEDNESDAY, March 19, 2025 -- In a 2024 clinical practice guideline issued by th...

Few Nonsurgical Treatments Show Effectiveness for Low Back Pain

Few Nonsurgical Treatments Show Effectiveness for Low B...

Mar 19, 2025 0

WEDNESDAY, March 19, 2025 -- For acute low back pain, there is moderate-certain...

STAT+: ME/CFS research program shuts down at Columbia after Trump cuts

STAT+: ME/CFS research program shuts down at Columbia a...

Mar 19, 2025 0

ME/CFS, which affects millions of Americans, has few dedicated research centers....

Dexcom survey shows healthcare providers opt for CGM tech over new medications in Type 2 diabetes

Dexcom survey shows healthcare providers opt for CGM te...

Mar 19, 2025 0

Dexcom found that just over half of healthcare providers ranked technology and e...

Cargo shelves cell therapy research, lays off more staff

Cargo shelves cell therapy research, lays off more staff

Mar 19, 2025 0

CEO Gina Chapman is also departing the company, which plans to review options fo...

Optum Rx says it will eliminate some prior authorization requirements

Optum Rx says it will eliminate some prior authorizatio...

Mar 19, 2025 0

The PBM plans to stop requiring coverage reauthorization for about 80 drugs, inc...

Newfound bacterial compound kills fungi that are resistant to multiple antifungals

Newfound bacterial compound kills fungi that are resist...

Mar 19, 2025 0

As fungi resistant to traditional treatments continue to spread around the globe...

Human medicines European public assessment report (EPAR): Namuscla, mexiletine hcl, Date of authorisation: 18/12/2018, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Namuscla, mexiletine h...

Immunovant claims study success for immune disease drug but holds off on submission

Immunovant claims study success for immune disease drug...

Mar 19, 2025 0

The company continues to focus on a next-generation drug while batoclimab’s test...

PSUSA/00010511/202407

PSUSA/00010511/202407

Mar 19, 2025 0

PSUSA/00010511/202407

Human medicines European public assessment report (EPAR): Tenofovir disoproxil Zentiva, tenofovir disoproxil, Date of authorisation: 15/09/2016, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Tenofovir disoproxil Z...

Human medicines European public assessment report (EPAR): Jayempi, azathioprine, Date of authorisation: 21/06/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Jayempi, azathioprine,...

Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Pomalidomide Krka, pom...

Human medicines European public assessment report (EPAR): Leflunomide ratiopharm, leflunomide, Date of authorisation: 28/11/2010, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Leflunomide ratiopharm...

Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Date of authorisation: 20/05/2016, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Pandemic influenza vac...

Purdue Pharma files new $7.4B bankruptcy reorganization plan to settle opioid claims

Purdue Pharma files new $7.4B bankruptcy reorganization...

Mar 19, 2025 0

After a federal guilty plea in 2020, the former OxyContin drugmaker is required ...

Human medicines European public assessment report (EPAR): Tolura, telmisartan, Date of authorisation: 04/06/2010, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Tolura, telmisartan, D...

Synchron and Nvidia set sights on AI model trained by direct brain activity

Synchron and Nvidia set sights on AI model trained by d...

Mar 19, 2025 0

The brain-computer interface developer Synchron has laid out plans to build an A...

Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Rivastigmine Actavis, ...

86
87
88
89
90

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.